Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06229444 · ClinicalTrials.gov registry record · NA
Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI
A NA study, sponsored by Evidation Health.
- Completed
- Registry status
- NA
- Development phase
- 17,043
- Enrollment target
NCT06229444: Completed NA study, sponsored by Evidation Health.
NCT06229444 is a NA study that has completed, run by Evidation Health. The registered enrollment target is 17,043 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1115% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06229444, a NA study, has completed, sponsored by Evidation Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 17,043 participants
- Enrollment target
Study Summary
The goal of this prospective, digital randomized controlled trial is to evaluate the effectiveness of a predictive ILI detection algorithm and associated alerts during influenza season for adults living in the contigent United States. The main study objectives are to assess the effectiveness of predictive ILI detection algorithm and associated alerts on protective behaviors related to ILI and assess the accuracy of a predictive ILI detection algorithm using participant self-reported ILI symptoms and diagnosis.
Primary Outcome
The difference between the predictive alert and the no predictive alert groups in the proportion of cohort members who performed any target health behavior 1-4 (i.e. performed at least one of: reduced spread, tested, sought medical attention, or was treatment adherent)
Interventions
- BEHAVIORAL No Intervention
- BEHAVIORAL ILI Predictive Alerts, Reactive Content, and Proactive Content
- BEHAVIORAL ILI Predictive Alerts, Reactive Content
- BEHAVIORAL Proactive Content
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,043 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2024-09-06 |
| Phase | NA |
What the finished NCT06229444 record still lists
NCT06229444 is an interventional study that assigns participants to a tested intervention. Its 17,043 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1115% higher).
The record links to 0 conditions, and to 4 interventions - of which No Intervention is the first listed.
NCT06229444 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06229444 about?
NCT06229444 is a clinical study titled "Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI". The goal of this prospective, digital randomized controlled trial is to evaluate the effectiveness of a predictive ILI detection algorithm and associated alerts during influenza season for adults living in the contigent United States. The main study objectives are to assess the effectiveness of pred...
What is the current status of trial NCT06229444?
This trial is currently completed. It is a NA study. The enrollment target is 17,043 participants. The study started on 2024-02-12. Estimated completion is 2024-09-06.
What interventions are being tested in trial NCT06229444?
The interventions under investigation include: No Intervention (BEHAVIORAL), ILI Predictive Alerts, Reactive Content, and Proactive Content (BEHAVIORAL), ILI Predictive Alerts, Reactive Content (BEHAVIORAL), Proactive Content (BEHAVIORAL).
Who is sponsoring clinical trial NCT06229444?
This trial is sponsored by Evidation Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06229444's enrollment target sits among peer trials
17,043 11th of 2000 higher than 1,990 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06479447 · 17,000 participants · NA
Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder
- NCT06948838 · 16,895 participants · NA
Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
- NCT06245187 · 17,198 participants
Get With the Guidelines Atrial Fibrillation Registry
- NCT06951867 · 16,640 participants
Tezspire Cardiac Events PASS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI